| NMB | neuromedin B; neuromuscular blockade; neuromuscular blocking; neuromuscular blocker/blocking [drug, ... |
|---|---|
| NMT | neuromuscular tension; neuromuscular transmission; N-methyltransferase; N-myristoyltransferase; no m... |
| DMR | depolarizing muscle relaxant; Diploma in Medical Radiology |
| MR | Maddox rods; magnetic resistance; magnetic resonance; mandibular reflex; mannose-resistant; may repe... |
| NDMR | nondepolarizing muscle relaxant |
| EDRF | endothelium derived relaxant factor |
|---|---|
| FNS | Functional Neuromuscular Stimulation |
| NM | Neuromuscular |
| NMD | Neuromuscular Diseases |
| NMB | Neuromuscular block |
| neuromuscular relaxant | An agent, e.g., curare or succinylcholine, that produces relaxation of striated muscle by interruption of transmission of nervous impulses at the myoneural junction. (05 Mar 2000) |
|---|
| relaxant | 1. Lessening or reducing tension. 2. <pharmacology> An agent that lessens tension. Origin: L. Relaxare = to loosen (18 Nov 1997) |
|---|---|
| relaxant reversal | Use of acetylcholinesterase inhibitors to terminate the action of nondepolarising neuromuscular relaxants. (05 Mar 2000) |
| muscle relaxant | <pharmacology> An agent that specifically AIDS in reducing muscle tension, as those acting at the polysynaptic neurons of motor nerves (for example meprobamate) or at the myoneural junction (curare and related compounds). Origin: L. Relaxare = to loosen (18 Nov 1997) |
| smooth muscle relaxant | An agent, such as an antispasmodic, bronchodilator, or vasodilator, that reduces the tension or tone of smooth (involuntary) muscle. (05 Mar 2000) |
| nondepolarising relaxant | An agent, e.g., tubocurarine, that paralyzes skeletal muscle without depolarisation of the motor endplate, as in phase II block. (05 Mar 2000) |
| depolarising relaxant | <pharmacology, physiology> An agent, e.g., succinylcholine, that induces depolarisation of the motor endplate and so paralyzes skeletal muscle by a phase I block. (05 Mar 2000) |
| neuromuscular | <anatomy> Pertaining to muscles and nerves. (18 Nov 1997) |
| neuromuscular agents | Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (neuromuscular blocking agents), and drugs that act centrally as skeletal muscle relaxants (muscle relaxants, central). Drugs used in the treatment of movement disorders are anti-dyskinesia agents. (12 Dec 1998) |
| neuromuscular blockade | The intentional interruption of transmission at the neuromuscular junction by external agents, usually neuromuscular blocking agents. It is distinguished from nerve block in which nerve conduction is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce muscle relaxation as an adjunct to anaesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anaesthesia but is grouped here with anaesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here. (12 Dec 1998) |
| neuromuscular blocking agent | A group of drugs that prevent motor nerve endings from exciting skeletal muscle. They act either by competing for the neurotransmitter, acetylcholine, (like D-tubocurarine, mivacurium and pancuronium), or by first stimulating the postjunctional muscle membrane and subsequently desensitizing the muscle endplates to the acetylcholine (like succinylcholine or decamethonium); used in surgery to produce paralysis and facilitate manipulation of muscles. (05 Mar 2000) |
| neuromuscular blocking agents | Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (neuromuscular nondepolarising agents) or noncompetitive, depolarising agents (neuromuscular depolarising agents). Both prevent acetylcholine from triggering the muscle contraction and they are used as anaesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc. (12 Dec 1998) |
| neuromuscular cell | A cell of a lower metazoan organism that is both sensitive and contractile. (05 Mar 2000) |
| neuromuscular depolarising agents | Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarisation of the motor end plate. These agents are primarily used as adjuvants in surgical anaesthesia to cause skeletal muscle relaxation. (12 Dec 1998) |
| neuromuscular junction | A chemical synapse between a motoneuron and a muscle fibre. Synonym: motor end plate. (18 Nov 1997) |
| neuromuscular nondepolarising agents | Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarisation of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anaesthesia adjuvants. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|